- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07699055
tACS Alters EEG Microstates in DoC
Transcranial Alternating Current Stimulation Is Associated With Changes in EEG Microstate Dynamics in Disorders of Consciousness
Disorders of consciousness (DoC), including unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), remain difficult to diagnose at the bedside. Electroencephalography (EEG) microstate analysis provides a high-temporal-resolution approach for characterizing large-scale resting-state brain dynamics, and its application in neuromodulation studies remains under investigation.
This study is designed to investigate the effects of a single 20-minute session of 40 Hz transcranial alternating current stimulation (tACS) applied over the bilateral dorsolateral prefrontal cortex (DLPFC) on resting-state EEG microstate parameters in patients with DoC. Participants undergo resting-state EEG recordings immediately before and after a 2 mA, 40 Hz bilateral DLPFC tACS session. EEG microstate maps (A-G) are identified by back-fitting to individual recordings, and microstate parameters including mean duration, occurrence, coverage, and global explained variance (GEV) are calculated. Behavioral assessments are performed using the Coma Recovery Scale-Revised (CRS-R) and the Simplified Evaluation of CONsciousness Disorders (SECONDs). The study aims to characterize changes in EEG microstate dynamics following tACS and to examine their associations with behavioral measures of consciousness.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Bağcılar
-
Istanbul, Bağcılar, Tyrkia (Türkiye)
- Medipol Mega University Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Adults aged 18 years or older.
- Medically stable at the time of assessment.
- No administration of sedative or hypnotic medication within the previous 24 hours.
- Preserved wakefulness (spontaneous or elicited by stimulation) with reduced or absent awareness, consistent with Unresponsive Wakefulness Syndrome (UWS) or Minimally Conscious State (MCS).
- Diagnosis confirmed by an experienced neurologist using repeated clinical assessments with the Coma Recovery Scale-Revised (CRS-R) and the Simplified Evaluation of CONsciousness Disorders (SECONDs) performed on different days and at different times during periods of wakefulness.
Exclusion Criteria:
- Acute phase of brain injury (within the first 28 days after injury).
- Administration of sedative or hypnotic medication within the previous 24 hours.
- Medical instability (e.g., active infection or hemodynamic instability).
- Epileptic seizures uncontrolled despite anticonvulsant therapy.
- Serious systemic illnesses that could affect the level of consciousness (e.g., sepsis or end-stage organ failure).
- Brain death or coma without any evidence of wakefulness.
- A previous history of developmental disorders, major neurological disorders, or severe psychiatric disorders associated with significant functional impairment.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Disorders of Consciousness and TACS
We evaluated the effect of a single 20-minute session of 40 Hz transcranial alternating current stimulation (tACS) over the bilateral dorsolateral prefrontal cortex (DLPFC) on resting-state EEG microstate parameters in DoC and their relationships with behavioral consciousness scores.
|
After completion of the first 20-minute resting-state EEG, tACS was applied using a Neurosoft / Neurostim device.
Stimulation was performed at the 40 Hz gamma frequency, with two stimulation electrodes placed bilaterally over the DLPFC.
According to the international 10-20 system, this placement corresponded to the F3 (left DLPFC) and F4 (right DLPFC) electrode positions.
The stimulation lasted 20 minutes, and a constant current intensity of 2 mA was used throughout.
The current was delivered as a sinusoidal waveform without phase shifting or modulation.
The electrodes were sponge-based pads measuring 5 × 7 cm each.
To improve conductivity and ensure homogeneous skin contact, the sponge electrodes were moistened with 0.9% isotonic sodium chloride (saline).
Electrodes were secured to the skin to optimize contact quality and homogenize current distribution.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Resting-State EEG Microstate Parameters
Tidsramme: Baseline and immediately after the 20-minute tACS session.
|
EEG recordings were obtained in different settings according to the patient's physical condition.
From every individual, a total of 20 minutes of resting-state EEG was obtained.
EEG recordings were performed using a Neurosoft NEURON-SPECTRUM-4 device and Neuron-Spectrum.NET software.
Recordings were obtained from 19 electrode channels positioned according to the international 10-20 system: Fp1, Fp2, F7, F3, Fz, F4, F8, T7, C3, Cz, C4, T8, P7, P3, Pz, P4, P8, O1, O2.
Data were digitized at a sampling rate of 500 Hz.
Resting-state electroencephalography (EEG) microstate parameters, including mean duration, occurrence, coverage, and global explained variance (GEV) of microstate classes A-G, derived from 19-channel scalp EEG recordings using microstate analysis.
|
Baseline and immediately after the 20-minute tACS session.
|
|
Coma Recovery Scale-Revised (CRS-R)
Tidsramme: Baseline and immediately after the 20-minute tACS session.
|
The CRS-R is a standardized clinical assessment tool used to evaluate the level of consciousness in patients with disorders of consciousness.
It consists of six subscales: auditory, visual, motor, oromotor/verbal, communication, and arousal.
The total score ranges from 0 to 23, with higher scores indicating a higher level of consciousness.
Diagnostic interpretation is based not only on the total score but also on the highest behavioral responses observed within each subscale.
|
Baseline and immediately after the 20-minute tACS session.
|
|
Simplified Evaluation of CONsciousness Disorders (SECONDs)
Tidsramme: Baseline and immediately after the 20-minute tACS session.
|
The SECONDs is a brief bedside assessment designed for the rapid evaluation of patients with disorders of consciousness.
It assesses arousal and behavioral responses to simple commands and environmental stimuli.
The total score ranges from 0 to 8, with higher scores indicating a better level of consciousness.
It is a practical tool for screening and longitudinal clinical monitoring.
|
Baseline and immediately after the 20-minute tACS session.
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Nevrologiske manifestasjoner
- Sykdommer i nervesystemet
- Psykiske lidelser
- Nevroatferdsmanifestasjoner
- Nevrokognitive lidelser
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Bevissthetsforstyrrelser
- Terapeutikk
- Atferdsdisipliner og aktiviteter
- Elektrisk stimuleringsbehandling
- Krampaktig terapi
- Psykiatriske somatiske terapier
- Electroshock
- Psykologiske teknikker
- Transkraniell likestrømstimulering
Andre studie-ID-numre
- 10840098-772.02-47943
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .